KNE Share Price

Open 0.12 Change Price %
High 0.12 1 Day 0.00 0.00
Low 0.12 1 Week 0.01 9.09
Close 0.12 1 Month -0.01 -7.69
Volume 13500 1 Year 0.08 200.00
52 Week High 0.18
52 Week Low 0.02
KNE Important Levels
Resistance 2 0.12
Resistance 1 0.12
Pivot 0.12
Support 1 0.12
Support 2 0.12
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PHM 0.40 -4.76%
PHM 0.40 -4.76%
PHM 0.40 -4.76%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
More..
CVE Canada Top Gainers Stocks
BVQ 0.02 100.00%
BGS 0.02 100.00%
BGS 0.02 100.00%
DDX 0.50 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
RDM 0.21 90.91%
SHM 0.24 71.43%
SHM 0.24 71.43%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
GB 0.10 -41.18%
GB 0.10 -41.18%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Kane Biotech Inc (CVE: KNE)

KNE Technical Analysis 3
As on 23rd May 2017 KNE Share Price closed @ 0.12 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.05 & Buy for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
KNE Target for May
1st Target up-side 0.15
2nd Target up-side 0.16
3rd Target up-side 0.17
1st Target down-side 0.11
2nd Target down-side 0.1
3rd Target down-side 0.09
KNE Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.kanebiotech.com
KNE Address
KNE
162-196 Innovation Drive
Winnipeg, MB R3T 2N2
Canada
Phone: 204-453-1301
Fax: 204-474-7552
KNE Latest News
Kane Biotech Inc (KNE.V) Needle Moving on Volume   Concord Register   - 23rd May 17
Kane Biotech - Q1 2017 Financial Reports   Marketwired (press release)   - 18th May 17
BRIEF-Kane Biotech says entered into license and distribution agreement with ...   Reuters   - 06th Mar 17
Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra   Marketwired (press release)   - 06th Mar 17
Kane Biotech Announces End of Joint Development Agreement and Appointment of ...   Marketwired (press release)   - 12th Jul 16
Philip Renaud Files Early Warning Report in Respect of Kane Biotech Inc.   Marketwired (press release)   - 06th May 16
BRIEF-Kane Biotech qtrly loss per share $0.005   Reuters   - 01st Jan 16
Ahrens-Townsend named new CEO of Kane Biotech   Winnipeg Free Press   - 12th May 15
Kane Biotech Introduces bluestemâ„¢   Marketwired (press release)   - 12th Feb 15
Kane Biotech Appoints Dr. Sarah Prichard, MD to the Board of Directors   Marketwired (press release)   - 02nd Apr 14
Interactive Technical Analysis Chart Kane Biotech Inc ( KNE CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Kane Biotech Inc
KNE Business Profile
Kane Biotech Inc., a biotechnology company, is engaged in the development and commercialization of products to prevent and remove biofilms. Its products include DispersinB, an antibiofilm enzyme for the wound care market; Aledex for the medical device coating market; KBI antibacterial disinfectant; and StrixNB for the oral care market. The company was founded in 2001 and is based in Winnipeg, Canada.